Mr. Christensen was named interim CEO in September after the district’s CEO, Conrado Bárzaga, MD, left his role Sept. 25.
Dr. Bárzaga filed a wrongful termination claim March 25, suggesting that he was terminated by the district board “without cause and in violation of his contract and California law.”
Mr. Christensen has been with the district since 2014, where he started out as a controller. Prior to his new role, Mr. Christensen also served as the district’s CFO for five years and has been district interim CEO three times.
Editor’s note: This story was updated May 29 at 12:40 p.m. CT.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
